Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of ALLO-ASC-DFU for second-degree burn injuries has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injury

Drugs mentioned

• ALLO-ASC-DFU

Snippet

Sponsor: Anterogen Co., Ltd. | Conditions: Burn Injury | Phase 2 | Status: COMPLETED